<SEC-DOCUMENT>0001178913-25-001260.txt : 20250410
<SEC-HEADER>0001178913-25-001260.hdr.sgml : 20250410
<ACCEPTANCE-DATETIME>20250410160025
ACCESSION NUMBER:		0001178913-25-001260
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250410
FILED AS OF DATE:		20250410
DATE AS OF CHANGE:		20250410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CERAGON NETWORKS LTD
		CENTRAL INDEX KEY:			0001119769
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30862
		FILM NUMBER:		25828267

	BUSINESS ADDRESS:	
		STREET 1:		3 URI ARIAV ST.
		STREET 2:		PO BOX 112
		CITY:			ROSH HA AYIN
		STATE:			L3
		ZIP:			4810004810
		BUSINESS PHONE:		972-3-543-1000

	MAIL ADDRESS:	
		STREET 1:		3 URI ARIAV ST.
		STREET 2:		PO BOX 112
		CITY:			ROSH HA AYIN
		STATE:			L3
		ZIP:			4810004810

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GIGANET LTD
		DATE OF NAME CHANGE:	20000719
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2532905.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">UNITED STATES</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br>
        Washington, D. C. 20549</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM 6-K</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; margin-left: 4.5pt; line-height: 1.25; font-weight: bold;">REPORT OF&#160; FOREIGN&#160; PRIVATE&#160; ISSUER&#160; PURSUANT&#160; TO RULE 13a-16&#160; OR </div>
      <div style="text-align: center; margin-left: 4.5pt; line-height: 1.25; font-weight: bold;">15d-16&#160; UNDER THE&#160; SECURITIES&#160; EXCHANGE&#160; ACT&#160; OF&#160; 1934</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <div style="line-height: 1.25; font-weight: bold;">For the month of April 2025</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Commission File Number: 0-30862</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3e0bb4bf091b4bb7a717601fe8fd4ec2">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 16pt;">CERAGON NETWORKS LTD.</font>
                <hr align="center" style="height: 2px; width: 40%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
              </div>
              <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">3 Uri Ariav st., Bldg A, 7</font><font style="font-weight: bold;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel</font>
                <hr align="center" style="height: 2px; width: 40%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Address of principal executive offices)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Form 20-F&#160; &#9746;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F &#9744; </div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; margin-right: 7.5pt; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 18pt; margin-right: 2.55pt; margin-left: 7.3pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned, thereunto duly authorized.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" colspan="2">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">CERAGON NETWORKS LTD.</div>
              </td>
              <td valign="top" style="width: 11%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 4%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 11%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                <div style="text-align: left; line-height: 1.25;">Date: April 10, 2025</div>
              </td>
              <td valign="top" style="width: 4%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/ Ronen Stein</td>
              <td valign="top" style="width: 11%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 4%;">Name:</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Ronen Stein<font style="font-family: 'Times New Roman',Times,serif;"><br>
                </font></td>
              <td valign="top" style="width: 11%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 4%;">Title:</td>
              <td valign="top" style="width: 35%;">Chief Financial Officer</td>
              <td valign="top" style="width: 11%;">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div style="line-height: 1.25"> </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25;"><u>Exhibit</u></div>
              </td>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25;"><u>Description</u></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_a.htm">Exhibit A &#8211;</a></div>
              </td>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;"><a href="exhibit_a.htm">NOTICE OF 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS</a></div>
              </td>
            </tr>
            <tr>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_b.htm">Exhibit B &#8211;</a></div>
              </td>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;"><a href="exhibit_b.htm">PROXY CARD FOR THE 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS</a></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit_a.htm
<DESCRIPTION>EXHIBIT A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold; font-style: normal;">Exhibit A</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;"><u>CERAGON NETWORKS LTD</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr align="center" style="height: 2px; width: 40%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr align="center" style="height: 2px; width: 40%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;
        <div style="line-height: 1.25; font-weight: bold;">TO BE HELD ON MAY 15, 2025</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="line-height: 1.25;">Dear Shareholder,</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">Notice is hereby given that the 2025 Annual General Meeting of Shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) of Ceragon Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) will be held on Thursday, May 15, 2025 at 4:00 PM (Israel time), at the offices of the Company located at 3
          Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel (Telephone number: + 972-3-543-1596). The following matters are on the agenda for the Meeting (collectively, the &#8220;<font style="font-weight: bold;">Proposals</font>&#8221;):</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6cf020c3c8eb410488d41c0f0e4cf5fa">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To approve certain compensation terms for the Company&#8217;s Chief Executive Officer;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;<br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f0ff6f90d904fd69a3ebd7f41d541ac">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="line-height: 1.25;">To approve an equity consideration to each of the Company&#8217;s directors, as part of their compensation for service as such;
                  and</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">3.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2025 and for the year commencing January 1, 2026 and until immediately following the
                  next annual general meeting of shareholders, and to authorize the Board (with power of delegation to its Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its
                  services.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Our Board unanimously recommends that you vote &#8220;FOR&#8221; each of the Proposals.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Additionally, at the Meeting, shareholders will be provided with the opportunity to receive and consider the auditor&#8217;s report and the audited consolidated financial statements of the Company for
        the fiscal year ended December 31, 2024. This item will not involve a vote of the shareholders.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">Only shareholders of record at the close of business on&#160;Thursday,
          April 17, 2025, the record date for determining those shareholders eligible to vote at the Meeting, are entitled to receive notice of, and to vote at, the
          Meeting (including any postponements or adjournments thereof).</div>
        <div style="line-height: 1.25;">&#160;
          <div style="line-height: 1.25;">Proposal 1 requires the affirmative vote of
            the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon; provided that, the majority of the shares voted in favor of said proposals are not held by &#8220;controlling shareholders&#8221; or
            shareholders with &#8220;personal interest&#8221; in the approval of such proposals, not taking into account any abstention, or that the total number of shares referred to above that voted against these proposals, does not exceed two percent of the
            aggregate voting rights in the Company &#160;(&#8220;<font style="font-weight: bold;">Disinterested
              Majority</font>&#8221;), as described in more detail under Proposal 1.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">Each of proposals 2 and 3 requires the
          affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon.</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">Whether or not you plan to attend the Meeting, you are
            urged to promptly complete, date and sign the enclosed proxy card and to mail it in the enclosed envelope, which requires no postage if mailed in the United States, at your earliest convenience and in any event no later than 4:00 PM (Israel
            time) on Wednesday, May 14, 2025. Execution of your proxy will not deprive
            you of your right to attend the Meeting and vote in person, and you will have the right to revoke your proxy any time before it is exercised by following the procedures set forth in the Proxy Statement enclosed herein.</div>
        <div style="line-height: 1.25;">&#160;
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">If you hold ordinary shares of the Company through a bank, broker or other nominee (i.e., in &#8220;street name&#8221;) which is one of our
              shareholders of record at the close of market on Thursday, April 17,
              2025, or which appears in the participant listing of a securities depository on that date, you must follow the instructions included in the voting instruction form you receive from your bank, broker or nominee, and may also be able to submit
              voting instructions to your bank, broker or nominee by phone or via the Internet. Please be certain to have your control number from your voting instruction form ready for use in providing your voting instructions. If you hold your ordinary
              shares of the Company in &#8220;street name,&#8221; you must obtain a legal proxy from the record holder to enable you to participate in and to vote your ordinary shares of the Company at the Meeting (or to appoint a proxy to do so).</div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We intend to hold the Meeting in person and all shareholders are cordially invited to attend the Meeting in person. However, we may decide to hold the Meeting virtually on the above date and time
        instead of in person, in which case an announcement of such change will be furnished with the Securities and Exchange Commission (&#8220;<font style="font-weight: bold;">SEC</font>&#8221;) on a Report on Form 6-K as promptly as practicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Joint holders of shares should note that, pursuant to Article 69(b) of the Articles of Association of the Company (the &#8220;<font style="font-weight: bold;">Articles</font>&#8221;), a notice may be given by
        the Company to the joint holders of a share by giving notice to the first of the joint holders named in the Register of Shareholders with respect to the shares, and any notice so given shall be sufficient notice to the other joint holders of such
        share(s).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Joint holders of shares should also note that, pursuant to Article 32(d) of the Articles, the vote of the first of the joint holders named in the Register of Shareholders with respect to the
        share(s) will be accepted to the exclusion of the vote(s) of the other joint holder(s).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Two or more shareholders, present in person or by proxy, entitled to vote and holding together ordinary shares conferring in the
        aggregate thirty-three percent (33%) or more of the voting power of the Company, shall constitute a quorum at the Meeting. If within an hour from the time appointed for the Meeting a quorum is not present, the Meeting will be rescheduled for the
        following week and accordingly, will stand adjourned until Thursday, May 22,
        2025, at the same time and place. At such adjourned Meeting, any two (2) shareholders present in person or by proxy, shall constitute a quorum.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The last date for submitting a request to include a
          proposal in accordance with Section 66(b) of the Israeli Companies Law, 5759-1999 as supplemented by the Israeli Companies Regulations (Relief for Companies with Shares Registered for Trade in a Stock Exchange Outside of Israel) (the &#8220;<font style="font-weight: bold;">Foreign Listed Regulations</font>&#8221;), is Thursday, April 17, 2025. A copy of the Proxy Statement (which includes the full version of the proposed resolutions) and a proxy card is being distributed to shareholders and also furnished to
          the SEC, under cover of Form 6-K. Shareholders are also able to review the Proxy Statement at the &#8220;Investor Relations&#8221; portion of our website www.ceragon.com/investors
          or at our headquarters at 3 Uri Ariav st., PO Box 112, Rosh Ha&#8217;Ayin, Israel, 4810002, upon prior notice and during regular working hours (telephone number: +972- 3-543-1596) until the date of the Meeting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Whether or not you plan to attend the Meeting, it is important that your ordinary shares of the Company be represented and voted at the Meeting. Accordingly, after reading the
        Notice of Meeting of Shareholders and the Proxy Statement, please sign, date and mail the proxy card in the envelope provided. Detailed proxy voting instructions will be provided both in the Proxy Statement and in the proxy card.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We urge all of our shareholders to review our annual report for 2024 on Form 20-F filed with the SEC, which is available on our website at www.ceragon.com/investors or on the SEC&#8217;s website at
        www.sec.gov.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">We look forward to greeting as many of you as can attend the Meeting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sincerely</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;/s/Ilan Rosen</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ilan Rosen, Chairman of the Board of Directors</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">April 10, 2025</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">ii</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERAGON NETWORKS LTD</div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">3 Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel</div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <hr align="center" style="height: 2px; width: 15%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">PROXY STATEMENT</div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <hr align="center" style="height: 2px; width: 15%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
      <div style="line-height: 1.25; text-align: center;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">To Be Held on May 15, 2025</div>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">This Proxy Statement is furnished to the holders of Ordinary Shares, NIS 0.01 nominal value (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221; or &#8220;<font style="font-weight: bold;">Shares</font>&#8221;),
        of Ceragon Networks Ltd (&#8220;<font style="font-weight: bold;">we</font>,&#8221; &#8220;<font style="font-weight: bold;">Ceragon</font>&#8221; or the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) in connection with the solicitation by the Board of Directors of the
        Company of proxies for use at the Company&#8217;s 2025 Annual General Meeting of Shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;), or at any postponements or adjournments thereof.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">The Meeting will be held on Thursday, May 15,
          2025, at 4:00 PM (Israel time), at the offices of the Company, 3 Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PURPOSE OF THE ANNUAL GENERAL MEETING</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting, resolutions be adopted as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15e877b178a3416a96f7d9747b5813af">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To approve certain compensation terms for the Company&#8217;s Chief Executive Officer;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">2.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>
                  <div style="line-height: 1.25;">To approve an equity consideration to each of the Company&#8217;s directors, as part of their compensation for service as such;
                    and</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z92b89b39328449eaa7cc31f13365aea2">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2025 and for the year commencing January 1, 2026 and until immediately following the next
                annual general meeting of shareholders, and to authorize the Board (with power of delegation to its Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its
                services.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Additionally, at the Meeting, shareholders will be provided with the opportunity to receive and consider the auditor&#8217;s report and the audited consolidated financial statements of the Company for
        the fiscal year ended December 31, 2024. This item will not involve a vote of the shareholders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We intend to hold the Meeting in person and all shareholders are cordially invited to attend the Meeting in person. However, we may decide to hold the Meeting virtually on the above date and time
        instead of in person, in which case an announcement of such change will be furnished with the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;) on a Report on Form 6-K as promptly as practicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">RECORD DATE AND VOTING RIGHTS</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">Only holders of record of Ordinary Shares at the close of business on Thursday, April 17, 2025, the record date for determining those shareholders eligible to vote at the Meeting, will be entitled to notice
          of and to vote at the Meeting (including any adjournments or postponements thereof) (the &#8220;<font style="font-weight: bold;">Record Date</font>&#8221;). Each Ordinary Share issued and
          outstanding as of the close of market on the Record Date, is entitled to one vote on each of the Proposals to be presented at the Meeting.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">QUORUM</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">Under our current Articles, two or more shareholders,
            present in person or by proxy, entitled to vote and holding together Ordinary Shares conferring in the aggregate thirty-three percent (33%) or more of the voting power of the Company, shall constitute a quorum at the Meeting. If within an hour
            from the time appointed for the Meeting a quorum is not present, the Meeting will be rescheduled for the following week and accordingly, will stand adjourned until Thursday, May 22, 2025, at the same time and place. At such adjourned Meeting, any two (2) shareholders present in person or by proxy, shall constitute a quorum.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHARES OUTSTANDING</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">As of April 4, 2025, we had 88,929,716 Ordinary Shares issued and outstanding (this amount does not include 3,481,523 ordinary
            shares held by the Company as treasury shares). Equinti Trust&#160;Company, LLC
            is the transfer agent and registrar for the Ordinary Shares.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROXY PROCEDURE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">A form of proxy for use at the Meeting and a return envelope for the proxy are also enclosed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">If specification is made by a shareholder on the form of proxy, the Shares represented thereby will be voted in accordance with such specification. If any other matters are presented at the
        Meeting, the persons named in the attached form of proxy shall vote all shares represented by all executed proxies in their best judgment. If no direction is indicated with respect to one or more of the resolutions on the proxy, the proxy will be
        voted &#8220;FOR&#8221; each such resolution. On all matters considered at the Meeting, abstentions and broker non-votes will be treated as neither a vote &#8220;FOR&#8221; nor &#8220;AGAINST&#8221; the matter, but they will be counted in determining if a quorum is present. Broker
        non-votes are votes that brokers holding shares of record for their clients are, pursuant to applicable stock exchange or other rules, precluded from casting in respect of certain non-routine proposals because such brokers have not received
        specific instructions from their clients as to the manner in which such shares should be voted on those proposals.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Shareholders may revoke the authority granted by their execution of proxies at any time before the effective exercise thereof by: (i) filing with the Company a written notice of revocation or duly
        executed proxy bearing a later date (but not less than twenty-four (24) hours prior to the time fixed for the Meeting); or (ii) voting in person at the Meeting.&#160; However, if a shareholder attends the Meeting and does not elect to vote in person,
        his or her proxy will not be revoked. If a proxy is properly executed and received not less than twenty-four (24) hours prior to the time fixed for the Meeting, Ordinary Shares represented by such proxy will be voted in the manner described above.
        If you hold your shares in &#8220;street name&#8221; and do not provide your broker with voting instructions for the Meeting, your broker will not be permitted to vote your shares on non-routine&#160;proposals, resulting in a &#8220;broker non-vote.&#8221; Therefore, it is
        important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Proxies for use at the Meeting are being solicited by the Board of Directors chiefly by mail;&#160;however, certain officers, directors, employees and agents of the Company, none of whom will receive
        additional compensation for such solicitation, may solicit proxies by telephone, electronic mail or other personal contact. We may also retain an independent contractor to assist in the solicitation of proxies. If retained for such services, we
        will pay the related costs. The Company will bear the cost for the solicitation of the proxies, including postage, printing and handling, and will reimburse the reasonable expenses of brokerage firms and others for forwarding material to, and
        obtaining authority to execute proxies from, beneficial owners of Shares.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">Pursuant to the Companies Law, as supplemented by the Foreign Listed Regulations, any shareholder or shareholders of the Company
          holding at least five&#160;percent&#160;(5%) of the voting rights of the Company (with respect to the proposal of director nominees) or one&#160;percent&#160;(1%) (with respect to any other matter) of the voting rights of the Company, as required by the Companies
          Law as supplemented by Regulation 7A. of the Foreign Listed Regulations (the &#8220;<font style="font-weight: bold;">Proposing Shareholder(s)</font>&#8221;) may request that the Board of
          Directors include a matter on the&#160;agenda of a General Meeting to be held in the future, provided that the Board of Directors determines that the matter is appropriate to be considered at a General Meeting (a &#8220;<font style="font-weight: bold;">Proposal&#160;Request</font>&#8221;). In order for the Board of Directors to consider a Proposal&#160;Request and whether to include the matter stated therein in the agenda of a General Meeting,
          notice of the Proposal&#160;Request must be timely delivered in accordance with applicable law, and the Proposal&#160;Request must comply with the requirements of the Articles and any applicable law and stock exchange rules and regulations. The
          Proposal&#160;Request must be in writing, signed by the Proposing Shareholder(s)&#160;making such request, delivered, either in person or by registered mail, postage prepaid, to the Company&#8217;s offices at 3 Uri Ariav st., PO Box 112, Rosh Ha&#8217;Ayin, Israel, 4810002 c/o Chief Legal Officer. To be considered timely, a Proposal&#160;Request must be received by Thursday, April 17, 2025.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">In addition to any information required in accordance with applicable law, a Proposal&#160;Request must include the following: (i)&#160;the name, address, telephone number, fax number and email address of
        the Proposing Shareholder (or each Proposing Shareholder, as the case may be) and, if an entity, the name(s)&#160;of the person(s)&#160;that controls or manages such entity; (ii)&#160;the number of shares held by the Proposing Shareholder(s), directly or
        indirectly (and, if any of such shares are held indirectly, an explanation of how they are held and by whom), which shall be in such number no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence satisfactory to
        the Company of the record holding of such shares by the Proposing Shareholder(s)&#160;as of the date of the Proposal&#160;Request; (iii)&#160;the matter requested to be included on the agenda of a Meeting, all information related to such matter, the reason that
        such matter is proposed to be brought before the Meeting, the complete text of the resolution that the Proposing Shareholder proposes to be voted upon at the Meeting, and a representation that the Proposing Shareholder(s)&#160;intend to appear in person
        or by proxy at the meeting; (iv)&#160;a description of all arrangements or understandings between the Proposing Shareholders and any other person(s)&#160;(naming such person or persons) in connection with the matter that is requested to be included on the
        agenda and a declaration signed by all Proposing Shareholder(s)&#160;of whether any of them has a personal interest in the matter and, if so, a description in reasonable detail of such personal interest; (v)&#160;a description of all Derivative Transactions
        (as defined below) by each Proposing Shareholder(s)&#160;during the previous Thirty-Six (36)&#160;month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such
        Derivative Transactions; and (vi)&#160;a declaration that all of the information that is required under the Companies Law and any other applicable law and stock exchange rules and regulations to be provided to the Company in connection with such matter,
        if any, has been provided to the Company. Furthermore, the Board of Directors, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s)&#160;provide additional information necessary&#160;so as to&#160;include a matter in
        the agenda of a Meeting, as the Board of Directors may reasonably require.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">For the purposes hereof, a &#8220;Derivative Transaction&#8221; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or any
        of its affiliates or associates, whether of record or beneficial: (1) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (2) which otherwise provides any direct or
        indirect opportunity to gain or share in any gain derived from a change in the value of securities of the Company, (3) the effect or intent of which is to mitigate loss, manage risk or benefit from security value or price changes, or (4) which
        provides the right to vote or increase or decrease the voting power of, such Proposing Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement, interest or
        understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related
        fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the securities of the Company held by
        any general or limited partnership, or any limited liability company, of which such Proposing Shareholder is, directly or indirectly, a general partner or managing member.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Should changes be made to any item on the agenda for the Meeting after the publication of this Proxy Statement, we will communicate the changes to our shareholders through the publication of a
        press release, a copy of which will be furnished with the SEC on a Report on Form 6-K.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHAREHOLDER ENGAGEMENT</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We maintain an open and collaborative dialogue with our shareholders. Our relationship with our shareholders, is a vital part of our success, and our executive leadership team believes that active
        engagement with our investors is an important source of strategic insight. Direct and open shareholder engagement drives increased corporate accountability, improves decision making, and ultimately creates long-term value.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">During 2024, we continued our investor
          relations activities proactively conducting shareholder outreach which included reaching out to major shareholders, including in person meetings, one-on-one calls or video conferences. In addition to these conversations, we maintain ongoing
          dialogue with many of our investors through our investor relations program and have continued our effort to engage with stewardship and governance contacts
          throughout the year.</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">BENEFICIAL OWNERSHIP OF SECURITIES BY PRINCIPAL</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHAREHOLDERS AND MANAGEMENT</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The following table sets forth certain information, as of&#160; April 4, 2025, regarding: (i) all persons or entities known to the Company to beneficially own more than 5% of the Company&#8217;s Ordinary Shares; (ii) each &#8220;office holder&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>, as such term is defined in the Companies Law, of
        the Company (the &#8220;<font style="font-weight: bold;">Office Holders</font>&#8221;) known to the Company to beneficially own more than 1% of the Company&#8217;s Ordinary Shares; and (iii) all Office
        Holders as a group.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The information contained herein has been obtained from the Company&#8217;s records or from information furnished by the individual or
        entity to the Company or disclosed in public filings with the SEC. Except where otherwise indicated, and except pursuant to community property laws, we believe, based on information furnished by such owners, that the beneficial owners of the
        Ordinary Shares listed below have sole investment and voting power with respect to such Ordinary Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The shareholders listed below do not have any different voting rights from any of our other shareholders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The SEC defines &#8220;beneficial ownership&#8221; of a security to mean the possession, directly or indirectly, of voting power and/or investment
        power over such security.&#160; The &#8220;Number of Ordinary Shares Beneficially Owned&#8221; in the table below includes Ordinary Shares that may be acquired upon the (i)&#160;the exercise of any option, warrant or right, (ii)&#160;the conversion of a security, (iii)&#160;the
        power to revoke a trust, discretionary account or similar arrangement, or (iv)&#160;the automatic termination of a trust, discretionary account or similar arrangement. In computing the number of shares beneficially owned by a person and the percentage
        ownership of that person, ordinary shares subject to exercise of options or other rights (as set forth above)&#160;that are either currently exercisable or will become exercisable within sixty (60) days as of April 4, 2025. The Ordinary Shares that may be issued under these options are deemed to be outstanding for the purpose of determining the percentage owned by the person or group holding the options but are
        not deemed to be outstanding for the purpose of determining the percentage of ownership of any other person or group shown in the table.</div>
      <div style="line-height: 1.25">&#160;</div>
      <br>
      <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f3d9afe5ef248188791851863998277">

          <tr>
            <td style="width: -30.6pt;"><br>
            </td>
            <td style="width: 28.35pt; vertical-align: top;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div>The term &#8220;Office Holder&#8221; as defined in the Companies Law includes a director, the chief
                    executive officer, the chief business officer, the vice chief executive officer, the deputy chief executive officer, any other person fulfilling or assuming any of the foregoing positions without regard to such person's title, and any
                    manager who is directly subordinated to the chief executive officer.</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="z39e4d405e27f46418aacc29d938b5142" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Name of Beneficial Owner</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Number of Ordinary Shares Beneficially Owned</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Percentage of Ordinary Shares Beneficially Owned <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Greater than 5% Shareholders</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25;">Joseph D. Samberg <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">9,430,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">10.61</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); font-weight: bold;">Office Holders</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25;">All Office Holders as a group consisting of 19 people <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">987,530</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">1.11</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(1)</div>
            </td>
            <td style="width: 97%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="line-height: 1.25;">Based on 88,929,716&#160;Ordinary Shares issued and outstanding as of April 4, 2025 (this amount does not include 3,481,523 ordinary shares held by the Company
                  as treasury shares).</div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 97%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(2)</div>
            </td>
            <td style="width: 97%; vertical-align: top;">
              <div style="line-height: 1.25;">This information is derived from a Schedule&#160;13D/A filed with the SEC on February&#160;27, 2025.&#160;The Ordinary Shares are beneficially owned directly or indirectly by Joseph D. Samberg through the Joseph D. Samberg
                Revocable Trust (the &#8220;Revocable Trust&#8221;), of which Mr. Samberg serves as trustee, and entities controlled by Mr. Samberg (the &#8220;Trusts&#8221;). Mr. Samberg may be deemed to beneficially own the securities directly held by the Revocable Trust and
                the Trusts. Joseph D. Samberg&#8217;s address is 1091 Boston Post Road, Rye, NY 10580.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 97%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(3)</div>
            </td>
            <td style="width: 97%; vertical-align: top;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Each of the directors and senior management beneficially owns less than 1% of the outstanding ordinary shares as of
                  April 4, 2025 (including options held by each such
                  person and which are vested or shall become vested within 60 days of April 4, 2025) and have therefore not been separately listed.</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">For information relating to the compensation of our five most highly compensated Office Holders with respect to the year ended December 31, 2024, please see &#8220;Item 6. <font style="font-style: italic;">Directors, Senior Management and Employees</font> &#8211; B. <font style="font-style: italic;">Compensation</font> - <font style="font-style: italic;">b) Individual Compensation of Office Holders</font>&#8221; in our Annual Report for 2024, which
        was filed on Form 20-F with the SEC on March 25, 2025.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Results of the Annual Meeting</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The preliminary voting results will be announced at the Meeting. The final voting results will be tallied by the Company&#8217;s Chief Legal Officer based on the information provided by the Company&#8217;s
        transfer agent or otherwise and will be published on a Form&#160;6-K&#160;that we will file with the SEC after the Meeting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proxy Materials</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Copies of the proxy card, the notice of the&#160;Meeting&#160;and this Proxy Statement are available at&#160;www.ceragon.com/investors. Information about the Meeting can also be found on the&#160;&#8220;Investor
        Relations&#8221;&#160;section of our website. The contents of our and any other website are not incorporated by reference into this Proxy Statement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Assistance in Voting your Shares</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">If you have questions about how to vote your shares, you may contact Hadar Vismunski Weinberg, Chief Legal Officer at +972-54-888-5186.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 1</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">APPROVAL OF CERTAIN COMPENSATION TERMS FOR THE COMPANY&#8217;S CHIEF </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXECUTIVE OFFICER</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Under the Companies Law, arrangements regarding the compensation of a chief executive officer (&#8220;<font style="font-weight: bold;">CEO</font>&#8221;) of a publicly traded company should generally be
        consistent with such Company&#8217;s compensation policy (the &#8220;<font style="font-weight: bold;">Compensation Policy</font>&#8221;) and require the prior approval of the company&#8217;s compensation committee, board of directors and shareholders (provided that, the
        majority of the shares voted in favor of this proposal are not held by &#8220;controlling shareholders&#8221; or shareholders with &#8220;personal interest&#8221; in the approval of such proposal, as detailed below), in that order.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Following the approval of our Compensation Committee and Board, we now seek our shareholders&#8217; approval for the terms of office and employment proposed for Mr. Arazi for 2025 in his capacity as the
        Company&#8217;s Chief Executive Officer.</div>
      <div style="line-height: 1.25;">&#160;
        <div style="text-align: justify; line-height: 1.25;">Under his existing employment agreement, our CEO, Mr. Doron Arazi, is entitled to a gross annual base salary of NIS 1,242,000 (approximately $333,870, based on the exchange rate published by the Bank of
          Israel on April 4, 2025 (the &#8220;<font style="font-weight: bold;">Base Salary</font>&#8221;), plus
          customary fringe&#160;benefits which include, among others, managers&#8217; insurance, education fund, car expenses, long-term disability and life insurance. In addition, Mr. Arazi is entitled to a performance-based annual cash bonus and to an annual equity
          grant.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Corporate Governance</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">The Company maintains a high level of corporate governance standards in all respects, both in relation to the full independence of
            its Compensation Committee and Board as well as in relation to its compensation practices. The Company has adopted best practices in relation to executive compensation, including the adoption of a clawback policy for our directors and
            executives that is compliant with the updated NASDAQ rules. The Company stresses long term incentives and pay for performance, and maintains reasonable compensation levels, which are generally within the Company&#8217;s peer group median levels, in alignment with shareholders&#8217; interests.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Compensation Policy under the Israeli Companies Law &#8211; Imposes Forward Looking Limitations</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Our Compensation Policy sets the framework and boundaries for executive compensation (rather than actual individual entitlement to compensation) and provides the Compensation Committee and the
        Board with the authority to determine appropriate levels of compensation for each of the Company&#8217;s executives within those boundaries.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s objectives with respect to executive compensation are designed to link pay to performance, align executives&#8217; long-term interests with those of the Company and its shareholders, and
        provide competitive compensation packages that motivate the Company&#8217;s executives to excel. In addition, such objectives are intended to allow the Company to retain and attract talented and experienced executives who are essential to the Company&#8217;s
        ongoing growth and success.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">As previously mentioned, in addition to the restrictions and limitations imposed by our Compensation Policy, the Companies Law mandates that any arrangements regarding the compensation of our Chief
        Executive Officer must generally receive prior approval from the company's compensation committee, board of directors, and shareholders, in that order. Therefore, his compensation is subject to close scrutiny by our shareholders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Compensation Terms</u></div>
      <div style="margin-right: 3.25pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="margin-right: 3.25pt; line-height: 1.25;"><font style="font-weight: bold;">2025 Cash Bonus Plan</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Consistent with the Compensation Policy, and subject to the limitations set forth therein, the Company may determine, with respect to each year, the target and maximum annual cash bonuses, as well
        as related objectives and related weights, applicable thresholds and the formula for calculating the annual cash bonus payment to be granted to our CEO.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Taking into account numerous factors, including the provisions of the Compensation Policy and other relevant information and materials presented to them, our Compensation Committee and Board of
        Directors have resolved, and are recommending that the shareholders approve, the following annual bonus plan for calendar year 2025 for our CEO, including the following related objectives, parameters, weights and terms, calculated in accordance
        with the following principles (altogether, the &#8220;<font style="font-weight: bold;">CEO Cash Bonus Plan</font>&#8221;):</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21072e30987a43079ee357a1d1b87029">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>According to the CEO Cash Bonus Plan the &#8220;On-Target&#8221; bonus amount for the year 2025 will be equal to ten (10) months&#8217; base salary (the &#8220;<font style="font-weight: bold;">On-Target Bonus</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ee36252813b46f5a0008211b6fc1d00">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Financial Measurable Targets: Ninety percent (90%) of the targets forming part of the CEO Cash Bonus Plan will be measurable targets and will include financial measurable targets (the &#8220;<font style="font-weight: bold;">Financial
                  Measurable Targets</font>&#8221;). The proposed Financial Measurable Targets shall be as follows: seventy percent (70%) of the 2025 On Target Bonus shall be based on the Company&#8217;s non-GAAP operating profit targets, ten percent (10%) of the 2025
                On Target Bonus shall be based on the Company&#8217;s cash flow targets, and ten percent (10%) of the 2025 On Target Bonus shall be based on the Company&#8217;s booking targets, all to be determined based on the Company&#8217;s financial results for the year
                2025. These targets were determined based on the Company&#8217;s 2025 annual business targets at the beginning of 2025, together with the targets determined for the annual bonus plans of the entire Company&#8217;s management.&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze5c04e446dd44205a6f3a419917b9563">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Non-Measurable Criteria: ten percent (10%) of the targets forming part of the CEO Cash Bonus Plan will be non-measurable criteria, which shall be concluded by assessing the CEO performance during the year, his contribution to the
                achievement of the Company's goals, and his evaluation by the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-right: 4.5pt; line-height: 1.25;"><u>General Terms</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Our Compensation Committee and Board of Directors have set a minimum threshold score with respect to each of the Financial Measurable Targets, so that below a certain level of achievement, payment
        will not be made with respect to such Measurable Target, as well as a general plan threshold which is based on the achievement of a pre-determined measurable financial criteria, under which no annual cash bonus shall be paid to our CEO.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Further, our Compensation Committee and Board of Directors have resolved that the maximum annual bonus payment to our CEO will be capped at 250% of his On Target Bonus (the &#8220;<font style="font-weight: bold;">Maximum Payment Cap</font>&#8221;), which cap is in compliance with the Compensation Policy. Reaching the Maximum Payment Cap, in the opinion of the Compensation Committee and Board of Directors, is an extremely challenging
        task.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Subject to receipt of shareholders&#8217; approval of the above annual cash bonus for 2025 for Mr. Arazi (including the related objectives, weights and terms thereof), the Compensation Committee and the
        Board of Directors will determine, following their approval of the 2025 Company&#8217;s audited financial statements, and without the need for further shareholder approval, the actual bonus to be paid with respect to 2025 to Mr. Arazi, if any.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">2025 Equity Grant</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">The 2025 annual CEO equity grant is comprised of (a) options to purchase 133,333 Ordinary Shares with a 10% premium above the fair
        market value exercise price (the &#8220;<font style="font-weight: bold;">Options</font>&#8221;), the value of which is estimated, as of the date of this Proxy Statement, and calculated based on the
        average closing price of the Company&#8217;s Ordinary Shares on the Nasdaq for the period equal to thirty (30) consecutive trading days prior to the filing date of this Proxy Statement, at approximately $165,333; and (b) 66,667 restricted share units (the &#8220;<font style="font-weight: bold;">RSUs</font>&#8221; and together with the Options the &#8220;<font style="font-weight: bold;">Annual CEO Equity Grant</font>&#8221;), the value of which is estimated, as of the date of this Proxy Statement, at approximately $165,333.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The above dollar value of the Annual CEO Equity Grant
        may vary until the date of the Meeting, as the value of the proposed </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">CEO Equity Grant, </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">is calculated, based on the average closing price
        of the Company&#8217;s Ordinary Shares on the Nasdaq for the period equal to thirty (30) consecutive trading days prior to the date of this Proxy Statement, among other things.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The ratio between the Options and the RSUs under the Annual
        CEO Equity Grant is 50%/50% in value.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Taking into consideration the Annual CEO Equity
        Grant, our Compensation Committee and Board remain committed to maintaining low levels of dilution, below the 10% threshold recommended by the ISS (Institutional Shareholder Services) in its Israeli Proxy Voting Guidelines, with respect to any
        proposed, including under this Proxy Statement, and/or outstanding equity-based compensation plans, including under this Proxy Statement (currently at approximately
        7.44%).</div>
      <div style="line-height: 1.25;">&#160;
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The total value of the Annual CEO
          Equity Grant is estimated at $330,666, constituting approximately 34% of our
          CEO&#8217;s annual total compensation; such value is in line with the provisions of our Compensation Policy and is&#160;within the median range of the benchmark reviewed by
          the Compensation Committee and the Board of Directors, which consists of comparable companies. The additional terms under which the Annual CEO Equity Grant
          shall be provided are as follows:</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z46e09aaaa53e4de891e139c9f0ebbaea">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>
                <div style="text-align: justify; line-height: 1.25;">The Annual CEO Equity Grant shall be
                  granted on the date of this Meeting (the &#8220;<font style="font-weight: bold;">Grant Date</font>&#8221;);</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0e66a45f772b41de88bc4f245e55699f">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>
                <div style="text-align: justify; line-height: 1.25;">The exercise price of the Options under the
                    Annual CEO Equity Grant shall be equal to the average closing price of the Company&#8217;s Shares on the Nasdaq for the period equal to thirty (30) consecutive trading days immediately preceding the Grant Date, plus a 10% premium;</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z714d9e83489644fda4a2e83ad92fea1c">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Annual CEO Equity Grant shall vest over a period of four (4) years, in four (4) equal tranches following the Grant Date, with a one-year cliff, so that on each anniversary of the Grant Date, 25% of the total Annual CEO Equity Grant
                shall vest (subject to acceleration of vesting in the circumstances detailed below); and</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>
                  <div style="text-align: justify; line-height: 1.25;">The Annual CEO Equity Grant shall be
                    granted pursuant to the Company&#8217;s 2024 Equity Incentive Plan (the &#8220;<font style="font-weight: bold;">2024 Plan</font>&#8221;), and the grants shall be made through a trustee under
                    the &#8220;Capital Gains Route&#8221; of Section 102(b)(2) of the Ordinance.</div>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;<br>
          <div style="line-height: 1.25;">
            <div style="margin-right: 4.5pt; line-height: 1.25; font-style: italic;">Acceleration</div>
            <div style="line-height: 1.25;">&#160;
              <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The vesting of the Annual
                CEO Equity Grant will be subject to acceleration according to the following double trigger mechanism: in the event that by the date of the consummation of a Transaction (as defined in the Option Plan): (i) Mr. Arazi&#8217;s employment with the
                Company (or the surviving entity following a merger) is terminated not for (i) Cause (as defined in the Option Plan); or (ii) there is a change in Mr. Arazi&#8217;s position in the Company (or the surviving entity following merger) and Mr. Arazi
                is not offered to continue to be employed by the surviving entity in a senior position, equivalent to the position of the Company&#8217;s CEO prior to the Transaction, the vesting of all of the unvested equity awards included in the Annual CEO Equity Grant, as of such date, shall accelerate upon the consummation of the Transaction. Mr. Arazi shall undertake that in the event that he will
                sell any of the Annual CEO Equity Grant, the vesting of which accelerated as a result of this double trigger mechanism, he will remain employed by the
                Company (or the surviving entity following merger) for a six-month period following the consummation of the Corporate Transaction (subject to the Company&#8217;s or the surviving entity&#8217;s request) and the consideration received for such sale
                shall be held in escrow until the earlier of (i) the termination of Mr. Arazi&#8217;s employment, or (ii) the lapse of a six-month period following the consummation of the Transaction.</div>
            </div>
          </div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div style="margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">Special Cash Bonus</div>
        <div style="line-height: 1.25;">&#160;
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">From the commencement of his tenure as our Chief Executive Officer, Mr. Arazi has undertaken the
            responsibility of recovering an outstanding debt from one of our customers, which had resulted in credit loss expenses amounting to $12.3 million. Over the past year, Mr. Arazi successfully negotiated a settlement with this customer and
            personally spearheaded the collection efforts, ultimately recovering the majority of the debt. This recovery was achieved through the extensive efforts of the Company&#8217;s management, under the leadership of Mr. Arazi. Mr. Arazi dedicated
            significant effort to establishing and nurturing the business and legal frameworks necessary for the debt collection, thereby substantially broadening the scope and complexity of his responsibilities as CEO.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Accordingly, the Compensation
              Committee&#160; and the Board believe that it would be appropriate to reward Mr. Arazi for his efforts in connection with the abovementioned, by granting him a one-time special cash bonus in an amount of US$60,000 (the &#8220;<font style="font-weight: bold;">Special Cash Bonus</font>&#8221;), a sum which, in the opinion of the Committee
              and the Board, is appropriate considering the benefits to the Company associated with the collection of the debt, while reflecting the appreciation for his special contribution. In approving the Special Cash Bonus to Mr. Arazi, in their
              respective resolutions dated April 2, 2025 and April 9 2025, the Compensation Committee and Board reviewed Mr. Arazi&#8217;s terms of employment, and concluded that the Special Cash Bonus is reasonable and appropriate when taking into account his
              central role in pursuing and recovering the majority of the debt, and also when considering the terms of the Company&#8217;s current compensation policy, which allows the grant of a special cash bonus under special circumstances or in case of an
              exceptional contribution to the Company, in an amount that may be up to 100% of the executive&#8217;s annual base salary.&#160; The Special Cash Bonus constitutes approximately 15% of the CEO Base Salary.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Following the approval of the Compensation Committee and the Board, the approval of our shareholders is now
            being sought for the grant of the Special Cash Bonus to Mr. Arazi.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Additional Considerations Taken by the Compensation Committee and the Board of Directors when approving the
          abovementioned compensation terms proposed to be paid and/or granted to our CEO, Mr. Arazi</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">When considering the CEO Cash Bonus Plan, the Annual CEO
          Equity Grant and the Special Cash Bonus (together, the &#8220;<font style="font-weight: bold;">CEO Compensation Package</font>&#8221;), the Compensation Committee and Board of Directors analyzed all factors and considerations required under the Compensation Policy and the Companies Law, including, <font style="font-style: italic;">inter alia</font>: (i) the responsibilities and duties of Mr. Arazi, considering the size of the Company and the scope, complexity and nature of its operations; (ii) Mr. Arazi&#8217;s education,
        qualifications, expertise and extensive experience in the telecommunications industry in general, and his performance in his various roles in the past; (iii) the information included in the benchmark study presented to the Board of Directors,
        according to which the proposed compensation terms for Mr. Arazi are within the average and the median range of compensation terms of the chief executive officers&#160; of the Company&#8217;s Israeli peers, which is by itself within the average
        and median chief executive officers&#8217; compensation terms among peer companies in the U.S; (iv) market compensation trends; (v) the appropriate balance between the fixed components and the variable components comprising the proposed compensation, and
        the fact that the variable components are limited to maximums that are consistent with the requirement for a close link between payments to Mr. Arazi and the Company&#8217;s performance and increase of its profits, while protecting the interests of the
        Company and its shareholders; and (vi) examination of data regarding the ratio between the proposed compensation and the wages of the rest of the Company&#8217;s employees and, particularly, the ratio to the average wage and the median wage of such
        employees and the impact of the gaps between them on the labor relations in the Company, and determination that the said ratio is reasonable and will not adversely affect labor relations in the Company.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
      <div style="line-height: 1.25;">&#160;
        <div style="text-align: justify; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting
          thereon, is required for the approval of the CEO Compensation Package; provided that a Disinterested Majority of the shares voted in favor of this proposal.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Companies Law, as supplemented by the Foreign Listed Regulations, requires that each shareholder voting on a proposed resolution
          requiring a Disinterested Majority inform the Company whether or not he or she is a controlling shareholder or has a personal interest in the proposed resolutions. Under the Companies Law, in general, a person will be deemed to be a controlling
          shareholder if that person has the power to direct the activities of the company, otherwise than by reason of being a director or other office holder of the company, and a person is deemed to have a personal interest if any member of the
          shareholder&#8217;s immediate family, or the immediate family of a shareholder&#8217;s spouse, has a personal interest in the adoption of the proposals. In addition, you are deemed to have a personal interest if a company, other than Ceragon, which is
          affiliated with you, has a personal interest in the adoption of the proposals. Such company is a company in which you or a member of your immediate family serves as a director or CEO, has the right to appoint a director or the CEO, or owns five
          percent (5%) or more of the outstanding shares. However, you are not deemed to have a personal interest in the adoption of the proposals if your interest in such proposal arises solely from your ownership of our shares, or to a matter that is not
          related to a relationship with a controlling shareholder.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Please note that we consider it highly
          unlikely that any of our shareholders is a controlling shareholder or has a personal interest in this proposal</font>.&#160; However, as required under the Companies law, as supplemented by the Foreign Listed Regulations, you should actively inform
        Ceragon whether you are a controlling shareholder or have a personal interest in this proposal.</div>
      <div style="line-height: 1.25;">&#160;
        <div style="text-align: justify; line-height: 1.25;">As set forth in the Companies Law, if our shareholders oppose the approval of the compensation package for Mr. Arazi, the
          Compensation Committee and Board of Directors may nevertheless approve such terms, in &#8220;special cases&#8221;, after having held another discussion regarding such terms, on the basis of detailed reasoning that considered the rationale behind the
          shareholders&#8217; opposition and after determining that such approval is in the best interests of the Company.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Resolution</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting the following resolutions be adopted:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to approve the CEO Compensation Package all upon the terms described in this Proposal 1 of the Proxy Statement.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolutions.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%12%%%--><br>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 2</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">TO APPROVE AN EQUITY CONSIDERATION TO EACH OF THE COMPANY&#8217;S</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> DIRECTORS, AS PART OF THEIR COMPENSATION FOR SERVICE AS SUCH</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">According to the Companies Law, compensation paid to our directors require, in general, the approval of our Compensation Committee,
        Board of Directors and shareholders, in that order.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-style: italic;">Current Compensation for Service as Directors</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">At the 2024 Annual General Meeting (the &#8220;<font style="font-weight: bold;">2024 AGM</font>&#8221;), our shareholders approved the appointment of our Board members for a three-year term. During this tenure, they are entitled to cash compensation, which includes an annual fee, a per-meeting participation fee for
          attending Board and committee meetings (including the execution of written resolutions), and reimbursement for travel expenses incurred for meetings held outside their place of residence.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Additionally, our Board members are entitled to equity compensation. This compensation consists of an equal value mix of options to
          purchase Shares and restricted share units (&#8220;<font style="font-weight: bold;">RSU</font>s&#8221;), with respect to their three-year term as directors, as approved at the 2024 AGM. Our
          directors are also covered by a directors and officers (D&amp;O) liability insurance in effect at the time of their election and any subsequent policies purchased by the Company in accordance with the Compensation Policy. Furthermore, they
          receive exemption and indemnification letters from the Company, consistent with those previously provided to other directors.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;"><u>General</u></div>
      <div style="line-height: 1.25;">&#160;
        <div style="text-align: justify; line-height: 1.25;">In order to attract and retain the best qualified candidates to our Board, and similar to the practice previously set by our
          shareholders with respect to the remuneration of Board members, our Compensation Committee and Board of Directors have approved, and resolved to recommend to our shareholders to approve, the grant of equity awards to each of our members of the
          Board with respect to their remaining two year term of service as directors, as detailed below, in addition to the compensation terms described above.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Each of the directors of the Company shall be entitled an annual grant of equity (in addition to the equity award granted to our
          directors as the 2024 AGM (the &#8220;<font style="font-weight: bold;">2024 Grant</font>&#8221;), on the date of this Meeting, based on the mechanism and under the terms detailed below, without
          the need for further approval, to be granted at the date of this Meeting, and upon the first anniversary of this Meeting (i.e., on May 15, 2026) (each, a &#8220;<font style="font-weight: bold;">Grant Date</font>&#8221;), subject to his or her continuous service as our director.</div>
        <div style="line-height: 1.25;">&#160;
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-style: italic;">Mechanism and Terms</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze8b96715a72d4f3db928436afb3cf6b7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Each of our directors shall be granted an equal value mix of options to purchase Shares (the &#8220;<font style="font-weight: bold;">Options</font>&#8221;) and RSUs (the Options and the RSUs together, the &#8220;<font style="font-weight: bold;">Annual Equity Award</font>&#8221;);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc6da6e0fa2ec42dcbd180b018ddbab89" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The value of the Annual Equity Award shall be 33,000 USD for all non-executive directors, and with respect to the Chairman, 49,500 USD (&#8220;<font style="font-weight: bold;">Annual Equity Value</font>&#8221;);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9773db8a81a7421bb3fc591efd837346" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The actual number of Options and RSUs to be granted each year, bearing the foregoing Annual Equity Value, shall be determined based on the average closing price per
                Share as quoted on the NASDAQ Stock Market during the 30 consecutive trading days preceding the Grant Date (the &#8220;<font style="font-weight: bold;">Market Value</font>&#8221;);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z17ea0ea58b77406caff501369544e4c7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In case a director is appointed in between annual general meetings, in accordance with our Articles &#8211; the Annual Equity Award will be pro-rated according to the part
                of the year that has passed since the previous annual general meeting of shareholders.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0be40db4e8dc429ea08032e2839aa51f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Exercise Price: The exercise price of the Options will be equal to the Market Value plus a 10% premium, and the RSUs shall have an exercise price of NIS 0.01 per
                share, which is the par value of each Share;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6c9debda9cca41069dc2ddeaefee2d2d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If approved by our shareholders, the Annual Equity Award granted each year, as detailed above, will be fully vested on the Grant Date. The exercise price for the
                proposed grants shall be equal to the average closing price of the Company&#8217;s Shares on the Nasdaq Global Select Market for the period equal to thirty (30) consecutive trading days immediately preceding the Grant Date of each portion of the
                total grant, provided that with respect to Mr. Wadsworth, our director who is a U.S resident, we may adjust this calculation method to comply with Section 409A of the U.S. Internal Revenue Code of 1986, as amended. In addition, subject to
                an earlier expiry in accordance with the terms of the Option Plan (as defined below), the Annual Equity Award will expire upon the earlier of (i) six (6) years after the date of grant, or (ii) at such time as the closing price of the
                Company&#8217;s ordinary shares on Nasdaq falls below fifty percent (50%) of the exercise price detailed above and remains in such price or in a lower price for a period of at least 90 days (the &#8220;<font style="font-weight: bold;">Knockout</font>&#8221;), in which case the options shall be cancelled automatically.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6736d1227a1746979d10adaa2e34ebc6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(g)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Annual Equity Award will be made under the 2024 Plan and under the Capital Gains Route of Section 102(b)(2) of the Israeli Income Tax Ordinance (the &#8220;<font style="font-weight: bold;">Ordinance</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4f4a69e7d5c64b1ab3919f532a3a77e2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(h)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The grant of the Annual Equity Award is in line with the Compensation Policy, as the aggregate value of the annual equity-based compensation granted to each of our
                non-executive directors (taking into account both the Annual Equity Award and the 2024 Grant), does not exceed $150,000 (per annum). The grant of the Annual Equity Award to our Chairman is also in line with the Compensation Policy, which
                allows our Chairman to receive an aggregate value of annual equity based compensation of up to 3 times the annual equity based compensation of the other directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The proposed value of the Annual Equity Award detailed above was examined and evaluated by our Compensation Committee and Board in
        accordance with a peer group study; the peer group study is a compensation and benefit examination, included peer companies selected to provide an appropriate comparative model, based on appropriate similarities taking into account a number of
        factors, including: market capitalization, type of industry, location of listing of securities, level of revenues, number of employees, geographical considerations and other factors that are considered relevant for comparison. Following due
        consideration of the type and value of the Annual Equity Award, as well as the full compensation packages, granted to directors serving in companies included in the study, our Compensation Committee and Board have determined that the value of the
        total compensation paid to our directors, including the value of the proposed equity awards, is below the median range of total director compensation provided by our peer companies.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">When considering the proposed Annual Equity Award, our Compensation Committee and Board analyzed all factors and considerations
        required under our Compensation Policy and the Companies Law, including, <font style="font-style: italic;">inter alia</font>, the responsibilities and duties of our directors,&#160;the estimation of their expected contribution and the importance of our directors to the future growth and success of the Company. Our Compensation Committee and Board
        of Directors believe that the Annual Equity Award detailed above is in the best interests of the Company, as: (i) the Company competes on qualified individuals to serve on its Board, and therefore needs to provide them with an adequate compensation
        package, which is aligned with the common practice implemented by our peers; (ii) the Annual Equity Award detailed above aligns the interests of our directors with those of our shareholders; (iii) the Annual Equity Award detailed above will
        provide, together with the cash compensation and existing equity consideration (as applicable), an adequate recognition for the time, attention and expertise required by our directors; and (iv) the Annual Equity Award detailed above has a long term
        incentive value, while taking into account the interests of the Company&#8217;s shareholders and their dilution level. In this respect, our Compensation Committee and Board remain committed to maintaining low levels of dilution, below the 10% threshold
        recommended by the ISS (Institutional Shareholder Services) in its Israeli Proxy Voting Guidelines, with respect to any proposed and/or outstanding equity-based compensation plans (currently at approximately 7.44%).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The affirmative vote of holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon,
        is required for the approval of the Annual Equity Awards.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting the following resolutions be adopted:</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to approve the grant
        of the Annual Equity Awards to the Company&#8217;s non-executive directors, in the amounts and upon terms as described in this Proposal 2 of the Proxy Statement.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolutions.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">As all members of the Board of Directors have a personal interest in the foregoing proposed resolution, they each
        refrained from making a recommendation with respect to the applicable resolution relevant to them.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 3</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">RE-APPOINTMENT OF INDEPENDENT AUDITOR</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 23.75pt; line-height: 1.25;">The Companies Law and our Articles provide that a certified accountant be appointed as an independent auditor of
        the Company at the annual general meeting of shareholders of the Company, and that the independent auditor serve in this position until immediately following the date of the next annual general meeting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>General</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">At the Meeting, the shareholders will be asked to re-appoint Kost Forer Gabbay &amp; Kasierer, A member firm of EY Global (&#8220;<font style="font-weight: bold;">Kost Forer</font>&#8221;), as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2025 and for the year commencing January 1, 2026 and until
        immediately following the next annual general meeting of shareholders, and to authorize the Company&#8217;s Board of Directors, (with power of delegation to its Financial Audit Committee, to set the annual compensation of the independent auditor in
        accordance with the volume and nature of its services.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Kost Forer has served as the Company&#8217;s independent
          auditor since 2002 and has no relationship with the Company or with any affiliate of the Company except as auditor, tax consultant and as a provider of other services that relate to transactional activities. Our Financial Audit Committee
        and the Board of Directors believe that such limited non-audit functions do not affect the independence of Kost Forer<font style="font-style: italic;">.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">For information on the fees paid by the Company and its subsidiaries to the Kost Forer in each of the previous two fiscal&#160;years,
        please see&#160;&#8220;Item&#160;16C.&#160;Principal Accountant Fees and Services&#8221;&#160;in the Company&#8217;s Annual Report on Form&#160;20-F&#160;for the year ended December&#160;31, 2024, filed with the SEC on March 25, 2025.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">As a result of the combined provisions of the Israeli law, our Articles and the Sarbanes-Oxley Act of 2002, the appointment of the
        independent auditor requires the approval of the shareholders of the Company, and its compensation requires the approval of our Financial Audit Committee. The Company&#8217;s Financial Audit Committee&#160;and Board of Directors have reviewed and are satisfied with the performance of Kost Forer, and have recommended their re-appointment as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2025
        and for the year commencing January 1, 2026 and until immediately following the next annual general meeting of shareholders. Approval of that appointment is now being sought from the Company&#8217;s shareholders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The affirmative vote of holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon,
        is required for the re-appointment of Kost Forer as the Company's independent auditor.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Resolution</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">It is proposed that at the Meeting the following resolution be adopted:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 0pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to
        re-appoint Kost Forer Gabbay &amp; Kasierer, A member firm of EY Global, as the independent auditor of the Company for the fiscal year ending December 31, 2025, and for the year commencing January 1, 2026 and until immediately following the next
        annual general meeting of shareholders and to authorize the Board of Directors (with power of delegation to the members of the Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and
        nature of its services.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolution.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">RECEIPT AND CONSIDERATION OF THE AUDITOR&#8217;S REPORT AND</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">At the Meeting, our auditor&#8217;s report and the audited consolidated financial statements of the Company for the fiscal year ended
        December 31, 2024 will be presented. The Company will hold a discussion with respect thereto, as required by the Companies Law. <font style="font-weight: bold;">This item will not
          involve a vote of the shareholders</font>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The foregoing auditor&#8217;s report and the audited consolidated financial statements, as well as our Annual Report on Form 20-F for the
        year ended December 31, 2024 (filed with the SEC on March 25, 2025), may be viewed on our website &#8211; <u>www.ceragon.com/investors/financial-information</u> or
        through the EDGAR website of the SEC at <u>www.sec.gov</u>. Except as noted above under &#8220;Beneficial Ownership of Securities by Principal Shareholders and
        Management&#8221; and under Proposal 3 &#8220;Re-Appointment of Independent Auditor&#8221;, none of the auditor&#8217;s report, audited consolidated financial statements, Annual Report on Form 20-F or the contents of our website form part of the proxy solicitation
        material.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/Ilan Rosen</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ilan Rosen, Chairman of the Board of Directors</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">April 10, 2025</div>
      <div style="line-height: 1.25">&#160;<br>
      </div>
    </div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>exhibit_b.htm
<DESCRIPTION>EXHIBIT B
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit B</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">FORM OF PROXY CARD</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">May 15, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The shareholder(s) hereby appoint/s Ronen Stein and Hadar Vismunski Weinberg, Adv., or either one of them, as proxies, each with the
        power to appoint his substitute, and hereby authorize/s them to represent and to vote as designated on the reverse side of this Proxy, all of the ordinary shares of Ceragon Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;)&#160;held of record in the name of the undersigned at the close of business on Thursday, April 17, 2025,
        that the shareholder(s) is/are entitled to vote at the annual general meeting of shareholders to be held at 4:00 PM (Israel time), on Thursday May 15, 2025, at the offices of the Company, 3 Uri Ariav st., Rosh Ha&#8217;Ayin, Israel 4810002 and any
        adjournment or postponement thereof (the "<font style="font-weight: bold;">Meeting</font>").</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER(S).&#160; IF NO SUCH DIRECTIONS ARE
        MADE BY THE SHAREHOLDER, THIS PROXY WILL BE VOTED FOR EACH PROPOSAL, AND AS SUCH PROXIES DEEM ADVISABLE WITH DISCRETIONARY AUTHORIZATION ON SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING AND ANY ADJOURNMENT OR ADJOURNMENTS THEREOF.
        ABSTENTIONS WILL BE COUNTED AS PRESENT FOR PURPOSES OF DETERMINING A QUORUM BUT WILL NOT BE COUNTED IN CONNECTION WITH THE VOTE ON ANY PROPOSAL AS TO WHICH THE SHAREHOLDER HAS ABSTAINED.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;(Continued and to be signed on the reverse side)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">May 15, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Please date, sign and mail your proxy card in the envelope provided as soon as possible</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">
        <hr align="center" style="height: 2px; width: 70%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE BOARD OF DIRECTORS (THE &#8220;BOARD&#8221;) RECOMMENDS A VOTE &#8220;FOR&#8221; PROPOSALS NO. 1 TO 2 OF THE PROXY STATEMENT.</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE &#9746;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr align="center" style="height: 2px; width: 70%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zc5170317c58242afa0812a252c41cff5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 67.04%; vertical-align: top;">&#160;</td>
              <td style="width: 11.18%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
              </td>
              <td style="width: 10.17%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
              </td>
              <td style="width: 11.61%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;">&#160;</td>
              <td style="width: 11.18%; vertical-align: top;">&#160;</td>
              <td style="width: 10.17%; vertical-align: top;">&#160;</td>
              <td style="width: 11.61%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">1. Approval of certain compensation terms for Mr. Doron Arazi, the Company&#8217;s Chief Executive Officer,
                  including the CEO Cash Bonus Plan, the CEO Annual Grant.</div>
              </td>
              <td style="width: 11.18%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 10.17%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 11.61%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 11.18%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
              <td style="width: 10.17%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
              <td style="width: 11.61%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">2. To approve an equity consideration to each of the Company&#8217;s directors, as part of their compensation
                  for service as such.</div>
              </td>
              <td style="width: 11.18%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 10.17%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 11.61%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 11.18%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
              <td style="width: 10.17%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
              <td style="width: 11.61%; vertical-align: middle; text-align: center;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 67.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">3. To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent
                  auditor for the fiscal year ending December 31, 2025 and for the year commencing January 1, 2026 and until immediately following the next annual general meeting of shareholders, and to authorize the Board (with power of delegation to its
                  Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its services, as described in Proposal 3 of the Proxy Statement.</div>
              </td>
              <td style="width: 11.18%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 10.17%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
              <td style="width: 11.61%; vertical-align: top; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">
                <div style="text-align: center; line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">By executing this proxy card, the undersigned hereby confirms and declares that he, she, or it is not a
                  &#8220;controlling shareholder&#8221; and does not have a &#8220;personal interest&#8221; in any of the above proposals, except if he, she, or it has notified the Company in writing and in advance on the existence of a &#8220;personal interest&#8221; in the approval of any
                  of the above proposals.</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">If the undersigned or a related party of the undersigned is a controlling shareholder of the Company or
                  has such &#8220;personal interest&#8221; in any of the above proposals, please notify the Company immediately in writing.</div>
              </td>
            </tr>

        </table>
        <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: 400;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Under the Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), a person will be deemed to be a "Controlling Shareholder" if that person
          has the power to direct the activities of the company, other than by reason of serving as a director or other office holder of the company.</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Under the Companies Law, a person is deemed to have a personal interest if he/she or any member of his or her immediate family, or
          the immediate family of his or her spouse, has a personal interest in the adoption of the proposal; or if a company, other than Ceragon, that is affiliated with such person or affiliated with his or her spouse, has a personal interest in the
          adoption of the proposal. A company is deemed to be affiliated with a person if such company is a company in which such person or a member of such person&#8217;s immediate family serves as a director or chief executive officer, has the right to appoint
          a director or the chief executive officer, or owns 5% or more of the outstanding shares.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">PLEASE NOTE THAT IT IS HIGHLY UNLIKELY THAT YOU HAVE A PERSONAL INTEREST IN ANY OF THE ABOVE PROPOSALS.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">You are not deemed to have a personal interest in the adoption of a proposal if your interest in such proposal arises solely from
          your ownership of our shares.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">For further information regarding the definition of &#8220;Controlling Shareholder&#8221; or "Personal Interest", please see the explanation
          under Proposal 1 of the Proxy Statement.</div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">To change the address on your account, please check the box at right and indicate your new address in the address space above.&#160;&#160;&#160; &#9744;</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; margin-right: 1.3pt; line-height: 1.25;">Please note that changes to the registered name(s) on the account may not be submitted via this method.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Signature of Shareholder&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </u><u>&#160;</u>&#160; Date&#160;<u> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; <br>
        </u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Signature of Shareholder&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </u><u>&#160;</u>&#160; Date&#160;<u> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; </u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE:&#160; </font>Please sign exactly as your name or names appear on this Proxy.&#160; When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney,
        trustee or guardian, please give full title as such.&#160; If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized
        person.</div>
      <div style="line-height: 1.25;"> <br>
      </div>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
